After leading a $6 million investment for CuriMeta, St. Louis-based BJC HealthCare is embarking on a collaboration with the analytics startup that aims to use deidentified patient data to cure illnesses like heart disease, cancer and neurodegenerative conditions, Becker’s reports.
The funding round was co-led by BJC partner Washington University School of Medicine, also based in St. Louis. Read more.
